Antifibrotic therapy is a research domain and therapeutic strategy focused on understanding, developing, and evaluating interventions aimed at inhibiting or reversing pathological tissue fibrosis. It encompasses the investigation of pharmacological agents and other modalities to slow disease progression, mitigate organ dysfunction, and improve clinical outcomes in a range of fibrotic diseases.